Related Experiment Video

Updated: Aug 17, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer

Junko Sakaguchi1, Satoru Kyo, Taro Kanaya

  • 1Department of Obstetrics and Gynecology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan.

Gynecologic Oncology
|July 5, 2005
PubMed
Abstract

Insights

Endometrial cancers show reduced TGF-beta receptor type II (TbetaRII) expression and mutations, linked to mismatch repair deficiency. This dysfunction in TGF-beta signaling may drive endometrial carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Transforming growth factor beta (TGF-beta) is a cytokine that inhibits epithelial cell growth.
  • Disruption of TGF-beta signaling is implicated in various cancers.
  • Aberrant TGF-beta receptor expression or function plays a critical role in tumor development.

Purpose of the Study:

  • To investigate the aberrant expression and mutation of the TGF-beta receptor type II (TbetaRII) gene in endometrioid endometrial cancers.

Main Methods:

  • Real-time PCR to assess TbetaRII mRNA levels in cancer and normal tissues.
  • Bisulfite sequencing to analyze TbetaRII promoter methylation status.
  • Mutational analysis of the TbetaRII gene, specifically focusing on exon 3 polyadenine repeats.

Main Results:

  • Endometrial cancers exhibited significantly decreased TbetaRII mRNA expression compared to normal endometria.
  • TbetaRII promoter hypermethylation was not the primary cause of reduced expression.
  • Frameshift mutations in the TbetaRII gene were identified in 15.1% of endometrial cancers, particularly in those with microsatellite instability-high (MSI-H) phenotype or methylated MLH1 promoters.

Conclusions:

  • Decreased TbetaRII expression and TbetaRII gene mutations due to mismatch repair deficiency are frequent in endometrioid endometrial cancers.
  • These genetic alterations likely lead to loss of TGF-beta receptor function.
  • Impaired TGF-beta signaling may contribute to the development of endometrial cancer.

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...